EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.1.23 | Adenocarcinoma |
34133937 |
NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. |
unassigned |
0 |
| 2.7.1.23 | Carcinogenesis |
26806015 |
Functional annotation of rare gene aberration drivers of pancreatic cancer. |
ongoing research
unassigned |
4
0 |
| 2.7.1.23 | Endometrial Neoplasms |
34000661 |
Distinct clinical and genetic mutation characteristics in sporadic and Lynch syndrome-associated endometrial cancer in a Chinese population. |
causal interaction
diagnostic usage
unassigned |
2
2
0 |
| 2.7.1.23 | Hyperlysinemias |
24847004 |
Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. |
causal interaction
unassigned |
4
0 |
| 2.7.1.23 | Hyperlysinemias |
29388319 |
Clinical heterogeneity of mitochondrial NAD kinase deficiency caused by a NADK2 start loss variant. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 2.7.1.23 | Hypersensitivity |
16244906 |
NADK2, an Arabidopsis chloroplastic NAD kinase, plays a vital role in both chlorophyll synthesis and chloroplast protection. |
unassigned |
0 |
| 2.7.1.23 | Hypersensitivity |
16856986 |
NADK3, a novel cytoplasmic source of NADPH, is required under conditions of oxidative stress and modulates abscisic acid responses in Arabidopsis. |
causal interaction
unassigned |
1
0 |
| 2.7.1.23 | Mitochondrial Diseases |
25641397 |
MNADK, a long-awaited human mitochondrion-localized NAD kinase. |
unassigned |
0 |
| 2.7.1.23 | nad+ kinase deficiency |
29388319 |
Clinical heterogeneity of mitochondrial NAD kinase deficiency caused by a NADK2 start loss variant. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 2.7.1.23 | Neoplasms |
23197646 |
Enhanced degradation of dihydrofolate reductase through inhibition of NAD kinase by nicotinamide analogs. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
3
4
0 |
